Franco Fortunato
Arzt
Hat mitgewirkt an:
-
Tumor biomarkers that identify molecular subtypes and best responders to chemotherapy in patients with PDAC
-
Bile acid attenuate progression of pancreatic precursor lesions via Farnesoid X receptor in a mouse model
-
Chronic lipopolysaccharide exposure accelerates KrasG12D induced pancreatic tumorigenesis via upregulation of tumor-promoting factors
-
Metavert in combination with chemotherapeutics improves therapeutic efficacy in pancreatic cancer cells and human pancreatic ductal adenocarcinoma organoids